| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.06 | 0.6 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |